Biologics Samumed Phase 2b Trial in Knee Osteoarthritis Meets Primary Endpoints byJosh SandbergOctober 25, 2018
Biologics Bone Therapeutics announces single intra-articular injection of viscosupplement JTA-004 delivered higher pain reduction than the reference in first study in knee osteoarthritis byJosh SandbergOctober 17, 2018
